Ozempic maker’s stock surges. A trial of a new Novo Nordisk drug shows promise.
Read more at MarketWatch
-
Novo Nordisk shares pop on early-stage weight loss drug trial results
The Danish pharmaceutical giant reported positive early-stage results for its once weekly amycretin obesity drug.CNBC - 8h -
Novo Nordisk Shares Surge on New Obesity Drug Results
Novo Nordisk shares rose sharply after the Danish pharmaceutical giant said an experimental weight-loss shot helped patients lose 22% of their body weight in a clinical trial.The Wall Street Journal - 8h -
Obesity drugs Ozempic and Wegovy included in US price-cut talks
Novo Nordisk shares hit as government adds blockbuster weight-loss treatments to new round of negotiationsFinancial Times - Jan. 17 -
Ozempic Among the Next Drugs Up for Medicare Price Negotiations
The list of drugs account for $41 billion in annual Medicare spending, the Biden administration said.The Wall Street Journal - Jan. 17 -
White House says popular weight-loss drug Ozempic subject to Medicare talks
Analysts at Argus Research say the stock is now trading at 22 times its estimated 2025 earnings.MarketWatch - Jan. 17 -
Medicare announces weight-loss drugs, including Ozempic, will be up for price negotiations
The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, which includes Ozempic.NBC News - Jan. 17 -
Ozempic, Wegovy on list for Medicare drug price negotiations
The hugely popular medications Ozempic and Wegovy, used for diabetes and weight loss, will be included in the next round of talks to negotiate lower Medicare drug prices.CBS News - Jan. 17 -
Weight-loss drugs like Ozempic may be up for Medicare price negotiations — will Trump support it?
Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face an uncertain future in the incoming Trump administration.NBC News - Jan. 9 -
Ozempic maker Novo Nordisk, after trial disappointment, expands AI deal in potential $4.6 billion pact
At least four analysts weighed in on the prospects for Europe’s second-largest company, Novo Nordisk, after the Danish drugmaker reported disappointing results for its next-generation weight-loss ...MarketWatch - Jan. 8
More from MarketWatch
-
Corporate tax cuts don’t boost the economy — despite what many investors believe
Raising corporate taxes — not cutting them — frequently delivers faster economic growth.MarketWatch - 39m -
Target joins Walmart in pulling back on DEI. But this big retailer and its shareholders are staying the course.
Target said that it was ending its diversity, equity and inclusion goals as it tries to align itself with an “evolving external landscape.”MarketWatch - 2h -
‘My retirement is going to be a disaster’: I’m 59 and have $45,000 in my 401(k). I earn $72,000. Am I doomed?
“My student loans are burying me.”MarketWatch - 2h -
Trump tariff talk is heating up on Wall Street, signaling a rocky road ahead for investors
S&P 500 companies’ mentions of tariffs on earnings calls have surged, according to Citi Research.MarketWatch - 3h -
Trump says there are bigger China threats than TikTok. Here’s where he could be going wrong.
President Trump this week said “TikTok is largely about kids” and there are bigger threats. China hawks aren’t convinced.MarketWatch - 3h
More in Business
-
Existing-Home Sales in 2024 Were Slowest in Decades Amid High Mortgage Rates
The market perked up late in the year when interest rates eased, but affordability challenges yielded the fewest transactions since 1995.The New York Times - 18m -
5 Economic Forces that Could Shape Trump’s First Year of Presidency
The economy won’t exactly bend to Trump’s whims.Inc. - 30m -
Corporate tax cuts don’t boost the economy — despite what many investors believe
Raising corporate taxes — not cutting them — frequently delivers faster economic growth.MarketWatch - 39m -
Jim Cramer's week ahead: Fed meeting and Big Tech earnings
CNBC's Jim Cramer highlighted what he's paying attention to next week as Wall Street launches into earnings season.CNBC - 48m -
Amazon Prime Video Seeks Profit Boost from Live Sports
Live sports create valuable opportunities for targeted ad placements on Prime Video.Inc. - 53m